Pfizer

Open: 29.21 Close: 29.09 Change: -0.12

The 5 top things that an AI found about Pfizer Company Inc Stock... they will surprise you

This document will help you to evaluate Pfizer without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Pfizer are: Pfizer, Texas, twicedaily, pill, trial, development, vaccine, and the …

Concept Map

Semantic Network

Stock Summary

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products. Pfizer offers medicines and vaccines in various therapeutic areas. The company also provides biosimilars for chronic immune and inflammatory diseases.

Today's Summary

Pfizer announced Friday it will discontinue its twice-daily weight-loss pill, danuglipron. Patients in a mid-stage trial experienced high rates of side effects like nausea and vomiting. Pfizer said it will focus future development of the drug on a once daily version.

Today's News

Pfizer announced Friday it will discontinue its twice-daily weight-loss pill, danuglipron, after patients in a mid-stage trial experienced high rates of side effects like nausea and vomiting. Pfizer said it will focus future development of the drug on a once-daily version. Pfizer discontinued the development of another obesity drug in June. Pfizer leads first-in-human trials - clinical trials arena. US has a robust regulatory framework that encourages and supports clinical research. Texas Attorney General Ken Paxton accuses Pfizer of breaking the Texas Deceptive Trade Practices Act. Paxton is seeking more than $10 million in civil fines and a court order barring Pfizer from speaking publicly about the efficacy of its vaccine. Pfizer rejects the case for lack of merit. Texas sues Pfizer over covid-19 vaccine effectiveness claims (2) Texas Sues Pfizer Over Covid- 19 Vaccine Effectiveness Claims. Pfizer suspends development of its twice-daily obesity pill. Texas sues Pfizer over claims about COVID vaccine effectiveness. Pfizer hits new 52-week low after weight loss setback. Texas AG sues company for alleged Medicaid fraud over ADHD medication. Pfizer and Valneva complete Recruitment for Phase 3 VALOR Trial for Lyme Disease Vaccine Candidate, VLA15 12/4/2023 Pfizer Inc. discontinues development of twice-daily weight loss pill. Pfizer shareholders have endured a 40% loss from investing in the stock a year ago. Pfizer has dismissed Paxtons lawsuit as meritless. The suit cites the total 2021 death toll in the U.S., after Pfizers vaccine was available, as being higher than in 2020. The lawsuit also paints the American public as being unduly susceptible. Pfizer stock heads for lowest level since 2020 after obesity-drug setback. Pfizer cancels twice-daily weight-loss pill after disappointing trial results. Company was a darling stock during the pandemic thanks to its life-saving Covid-19.

Stock Profile

"Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Retacrit, Lorbrena, and Braftovi brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York."

Keywords

The game is changing. There is a new strategy to evaluate Pfizer fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Pfizer are: Pfizer, Texas, twicedaily, pill, trial, development, vaccine, and the most common words in the summary are: pfizer, best, credit, news, vaccine, health, business, . One of the sentences in the summary was: Pfizer said it will focus future development of the drug on a once daily version.. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #pfizer #best #credit #news #vaccine #health #business.